Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Notes Payables (2024 - 2025)

Orthopediatrics has reported Notes Payables over the past 2 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Notes Payables at $2.5 million for Q4 2025, up 73.08% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (up 73.08% YoY), and the annual figure for FY2025 was $2.5 million, up 73.08%.
  • Notes Payables for Q4 2025 was $2.5 million at Orthopediatrics, up from $1.3 million in the prior quarter.
  • Over the last five years, Notes Payables for KIDS hit a ceiling of $2.5 million in Q4 2025 and a floor of $1.3 million in Q3 2025.